International Edition
Latest News
Health

IARC Researchers Release 2026 Global Gastric Cancer Figures

Nearly one million people developed gastric cancer worldwide in 2024, while bacterial infections and regional disparities continued to drive most cases. Researchers from the International Agency for Research on Cancer reported that the disease caused approximately 650,000 deaths…

Gastric Cancer Awareness Month 2026: A Global Perspective on Risk, Prevention, and Progress

Nearly one million people developed gastric cancer worldwide in 2024, while bacterial infections and regional disparities continued to drive most cases. Researchers from the International Agency for Research on Cancer reported that the disease caused approximately 650,000 deaths that year, positioning stomach tumors as the fifth most common cancer globally.

Oncodaily reported that the awareness month originated from the non-profit organization No Stomach For Cancer, which was established in 2009. The organization worked alongside the United States Senate the following year to secure official recognition.

Senator Russ Feingold introduced Senate Resolution 655 with co-sponsor Senator Dick Durbin, successfully designating November 2010 as Gastric Cancer Awareness Month. Thanksgiving traditions and National Family History Day inspired the timing, as inherited predispositions can elevate personal risk within certain families.

Global Burden and Demographics

Researchers from the International Agency for Research on Cancer released updated global figures on November 3, 2026, placing gastric cancer as the fifth leading cause of cancer-related death worldwide. Men account for nearly two-thirds of all new diagnoses and fatalities.

Geographical distribution remains sharply uneven across populations. Asia bears the heaviest burden of the disease, with China alone responsible for more than one-third of all global cases and deaths.

Helicobacter Pylori Infection Risks

Infection with the spiral-shaped bacterium Helicobacter pylori accounts for approximately 760,000 new cancer cases, representing about three-quarters of the total global gastric cancer burden. The International Agency for Research on Cancer classifies the bacterium as a Group 1 carcinogen.

The microbe is frequently acquired during childhood and persists in the stomach lining for decades if left untreated. While the infection can cause chronic gastritis and peptic ulcers, most people harboring the bacterium never develop malignancy.

Progression Through the Correa Cascade

Pathologist Pelayo Correa described how persistent inflammation damages the stomach lining over many years or even decades. This multi-step process begins with chronic gastritis and can potentially advance to atrophic gastritis.

Cellular changes may then progress through intestinal metaplasia and dysplasia before culminating in gastric adenocarcinoma. Beyond typical adenocarcinomas, the bacterium also links directly to gastric mucosa-associated lymphoid tissue lymphoma, where eradicating the infection can occasionally lead to tumor regression.

The International Agency for Research on Cancer (IARC) functions as an intergovernmental agency and the specialized cancer research unit of the World Health Organization. Established by a 1965 resolution of the World Health Assembly, the organization is tasked with conducting and coordinating global research into the causes of cancer.

Its mandate includes the collection and publication of surveillance data, which informs the authoritative global cancer statistics used to track disease trends, such as the 2026 gastric cancer figures.

Beyond its statistical role, the agency operates the IARC Monographs programme, which began in 1970 to identify carcinogenic hazards.

Diagnosis and Clinical Symptoms

Early-stage stomach cancer frequently produces subtle symptoms or none at all, complicating timely detection. When clinical manifestations do appear, they often mirror common gastrointestinal ailments.

Persistent upper abdominal discomfort, unexplained weight loss, loss of appetite, and early satiety warrant medical evaluation. Physicians utilize upper gastrointestinal endoscopy alongside tissue biopsies to confirm diagnoses and establish appropriate treatment paths.

About the author: Health Desk

Health Desk at Archynewsy.